Alisa Krasnodubets

Ms. Alisa Krasnodubets


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
KLKateryna Laikova
Kateryna Laikova
Vol V. OberemokVol V. Oberemok
Vol V. Oberemok
AKAlisa Krasnodubets
Alisa Krasnodubets
Nikita V. Gal'chinskyNikita V. Gal'chinsky
Nikita V. Gal'chinsky
RURefat Zhevdetovich Useinov
Refat Zhevdetovich Useinov
Anatolii V KubyshkinAnatolii V Kubyshkin
Anatolii V Kubyshkin
Skin cancer has always been and remains the leader among all tumors in terms of occurrence. One of the main factors responsible for skin cancer, natural and artificial UV radiation, causes the mutations that transform healthy cells into cancer cells. These mutations inactivate apoptosis, an event required to avoid the malignant transformation of healthy cells. Among these deadliest of cancers, melanoma and its ‘younger sister’, Merkel cell carcinoma, are the most lethal. The heavy toll of skin cancers stems from their rapid progression and the fact that they metastasize easily. Added to this is the difficulty in determining reliable margins when excising tumors and the lack of effective chemotherapy. Possibly the biggest problem posed by skin cancer is reliably detecting the extent to which cancer cells have spread throughout the body. The initial tumor is visible and can be removed, whereas metastases are invisible to the naked eye and much harder to eliminate. In our opinion, antisense oligonucleotides, which can be used in the form of targeted ointments, provide real hope as a treatment that will eliminate cancer cells near the tumor focus both before and after surgery.